IQVIA Holdings Inc (IQV)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE
Market Cap: $43.69B
Last updated: Nov 17, 2026 at 11:06 AM ET
IQVIA Holdings Inc (IQV) Financials: Revenue, Profit and Cash Flow
IQVIA Holdings reported revenue of $16.31B for the fiscal year ended Dec 31, 2025, up 5.9% from the year before. That year, net income was $1.36B with a net margin of 8.3%, operating cash flow was $2.65B and free cash flow was $2.05B. The quarter ended Sep 30, 2026 had revenue of $4.43B and net income of $352.00M.
Revenue and Margins
The operating margin was 13.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $6.82B, a compound annual rate of 10.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $16.31B | +5.9% | 33.3% | 13.4% | 8.3% |
| Dec 2024 | $15.40B | +2.8% | 34.9% | 14.3% | 8.9% |
| Dec 2023 | $14.98B | +4.0% | 35.0% | 13.2% | 9.1% |
| Dec 2022 | $14.41B | +3.9% | 34.9% | 12.5% | 7.6% |
| Dec 2021 | $13.87B | +22.1% | 33.5% | 10.0% | 7.0% |
| Dec 2020 | $11.36B | +2.4% | 34.0% | 6.4% | 2.7% |
| Dec 2019 | $11.09B | +6.5% | 34.2% | 7.0% | 2.0% |
| Dec 2018 | $10.41B | +7.3% | 35.2% | 7.1% | 2.7% |
| Dec 2017 | $9.70B | +42.4% | 35.1% | 6.9% | 13.4% |
| Dec 2016 | $6.82B | N/A | 30.3% | 8.5% | 1.3% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 0.7% from the year before. In the quarter ended Sep 2026, net income rose 6.0% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.31B | $15.40B | $14.98B | $14.41B | $13.87B | $11.36B | $11.09B | $10.41B | $9.70B | $6.82B |
| Cost of revenue | $10.88B | $10.03B | $9.74B | $9.38B | $9.23B | $7.50B | $7.30B | $6.75B | $6.30B | $4.75B |
| Gross profit | $5.43B | $5.38B | $5.24B | $5.03B | $4.64B | $3.86B | $3.79B | $3.67B | $3.40B | $2.07B |
| Operating income | $2.18B | $2.20B | $1.98B | $1.80B | $1.39B | $731.00M | $777.00M | $741.00M | $665.00M | $576.00M |
| Net income | $1.36B | $1.37B | $1.36B | $1.09B | $971.00M | $308.00M | $227.00M | $284.00M | $1.30B | $87.00M |
| EBITDA | $3.45B | $3.43B | $3.24B | $2.91B | $2.80B | $2.10B | $2.03B | $1.89B | $1.68B | $909.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.43B | $4.37B | $4.15B | $4.36B | $4.10B | $4.02B | $3.83B | $3.96B | $3.90B | $3.81B | $3.74B | $3.87B |
| Gross profit | $1.50B | $1.44B | $1.35B | $1.44B | $1.37B | $1.32B | $1.30B | $1.38B | $1.38B | $1.33B | $1.29B | $1.39B |
| Operating income | $572.00M | $506.00M | $514.00M | $627.00M | $553.00M | $506.00M | $496.00M | $626.00M | $550.00M | $520.00M | $506.00M | $501.00M |
| Net income | $352.00M | $258.00M | $275.00M | $514.00M | $332.00M | $266.00M | $249.00M | $437.00M | $285.00M | $363.00M | $288.00M | $469.00M |
Balance Sheet
As of Dec 2025, total debt of $15.72B exceeded cash and equivalents by $13.74B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $29.94B | $26.90B | $26.68B | $25.34B | $24.69B | $24.56B | $23.25B | $22.55B | $22.86B | $21.21B |
| Current assets | $6.25B | $5.83B | $5.60B | $4.98B | $4.76B | $5.09B | $4.13B | $3.87B | $3.55B | $3.34B |
| Cash and equivalents | $1.98B | $1.70B | $1.38B | $1.22B | $1.37B | $1.81B | $837.00M | $891.00M | $959.00M | $1.20B |
| Total liabilities | $23.31B | $20.83B | $20.57B | $19.57B | $18.65B | $18.28B | $16.99B | $15.60B | $14.61B | $12.35B |
| Short-term debt | $1.84B | $1.15B | $718.00M | $152.00M | $91.00M | $149.00M | $100.00M | $100.00M | $103.00M | $92.00M |
| Long-term debt | $13.88B | $12.84B | $12.96B | $12.60B | $12.03B | $12.38B | $11.54B | $10.91B | $10.12B | $7.11B |
| Shareholder equity | $6.50B | $6.07B | $6.11B | $5.76B | $6.04B | $6.00B | $6.00B | $6.71B | $8.00B | $8.63B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $30.47B | $29.88B | $29.68B | $29.94B | $28.73B | $28.63B | $27.32B | $26.90B | $27.18B | $26.40B | $26.57B | $26.68B |
| Total liabilities | $23.68B | $23.58B | $23.33B | $23.31B | $22.44B | $22.85B | $21.34B | $20.83B | $20.21B | $19.68B | $20.23B | $20.57B |
| Cash and equivalents | $2.25B | $1.91B | $1.95B | $1.98B | $1.81B | $2.04B | $1.74B | $1.70B | $1.57B | $1.54B | $1.44B | $1.38B |
| Shareholder equity | $6.66B | $6.17B | $6.22B | $6.50B | $6.16B | $5.78B | $5.98B | $6.07B | $6.97B | $6.71B | $6.34B | $6.11B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 77.4% of operating cash flow. Share repurchases came to 60.5% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.65B | $2.72B | $2.15B | $2.26B | $2.94B | $1.96B | $1.42B | $1.25B | $970.00M | $860.00M |
| Capital expenditures | $603.00M | $602.00M | $649.00M | $674.00M | $640.00M | $616.00M | $582.00M | $459.00M | $369.00M | $164.00M |
| Free cash flow | $2.05B | $2.11B | $1.50B | $1.59B | $2.30B | $1.34B | $835.00M | $795.00M | $601.00M | $696.00M |
| Dividends paid | N/A | N/A | N/A | N/A | $758.00M | $13.00M | $18.00M | $31.00M | $7.16B | $0 |
| Share repurchases | $1.24B | $1.35B | $992.00M | $1.17B | $406.00M | $447.00M | $949.00M | $1.41B | $2.62B | $1.10B |
| Investing cash flow | -$2.31B | -$1.44B | -$1.60B | -$2.01B | -$2.10B | -$796.00M | -$1.19B | -$810.00M | -$1.19B | $1.73B |
| Financing cash flow | -$150.00M | -$878.00M | -$382.00M | -$329.00M | -$1.24B | -$217.00M | -$276.00M | -$452.00M | -$72.00M | -$2.28B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $825.00M | $558.00M | $618.00M | $735.00M | $908.00M | $443.00M | $568.00M | $885.00M | $721.00M | $588.00M | $522.00M | $747.00M |
| Capital expenditures | $158.00M | $198.00M | $127.00M | $174.00M | $136.00M | $151.00M | $142.00M | $164.00M | $150.00M | $143.00M | $145.00M | $179.00M |
| Free cash flow | $667.00M | $360.00M | $491.00M | $561.00M | $772.00M | $292.00M | $426.00M | $721.00M | $571.00M | $445.00M | $377.00M | $568.00M |
Frequently Asked Questions About IQV
What is IQVIA Holdings' annual revenue?
IQVIA Holdings reported revenue of $16.31B for the fiscal year ended Dec 31, 2025.
How fast is IQVIA Holdings' revenue growing?
Revenue was up 5.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 4.2%.
Is IQVIA Holdings profitable?
Yes. IQVIA Holdings reported net income of $1.36B for the fiscal year ended Dec 31, 2025, with a net margin of 8.3%.
How much free cash flow does IQV generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $2.65B minus capital expenditures of $603.00M produced free cash flow of $2.05B.
How much debt does IQVIA Holdings have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $13.88B, short-term debt of $1.84B and cash and equivalents of $1.98B.
IQV pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors